Drug Type Molecular glue |
Synonyms Salt form-GT19884 |
Target |
Mechanism GSPT1 inhibitors(G1 to S phase transition 1 inhibitors), MYC inhibitors(Myc proto-oncogene protein inhibitors), N-Myc inhibitors(MYCN proto-oncogene, bHLH transcription factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | CN | 08 Apr 2024 | |
Castration-Resistant Prostatic Cancer | Preclinical | CN | 08 Apr 2024 | |
Neuroblastoma | Preclinical | CN | 08 Apr 2024 | |
Small Cell Lung Cancer | Preclinical | CN | 08 Apr 2024 |